...in an April 27 memo, Colombian diplomat Andrés Flórez said he was worried the U.S. would withhold peace funding if the Colombian government lowered prices on the drug Gleevec, also sold as Glivec. The memo was first posted by the think tank Knowledge Ecology International.
Both the American government and Novartis, the Swiss pharmaceutical company that makes Gleevec, want to maintain high prices for the drug, according to the memo...
Like what is charged at Cone Health
Novartis charges nearly double Colombia’s per capita income for a year’s supply of Gleevec to treat a single patient. As a result, the Colombian government is considering issuing a much cheaper generic copy.
Which Cone Health won't do,
even though it says it's a 'non-profit'
In his letter to Colombian Minister of External Affairs María Ángela Holguín, Flórez suggested he felt pressure from both the Office of the U.S. Trade Representative — a division of the Obama White House — and members of the U.S. Congress with ties to the pharmaceutical industry.
Our local and state governments get pressure and lots of money
from companies who overcharge for prescriptions in North Carolina
to let Big Pharma continue to rip off taxpayers and patients
Senate Finance Committee Chairman Orrin Hatch (R-Utah) has received millions of dollars in campaign contributions from drug companies, and has benefitted from hundreds of thousands of dollars in pharmaceutical company donations to other outside groups. His son, Scott Hatch, has lobbied on behalf of the Pharmaceutical Research and Manufacturers of America — the top lobbying group for the prescription drug industry. The Senate Finance Committee has jurisdiction over U.S. trade policy.
Both sides in North Carolina get the same campaign checks
from health care industry lobbyists to maintain the pilfering of our citizens
...Both the Obama administration and Hatch have used trade policy to bolster the prescription drug industry. The administration has been especially aggressive with India on generic drugs, and has disappointed Doctors Without Borders and other global health groups with TPP, which included terms ensuring long-term drug company monopolies on lifesaving medications...
...U.S. trade policy has prioritized pharmaceutical company profits for decades. Both Republican and Democratic administrations have sought intellectual property rules that would grant drug firms long-term monopolies on their medications. Those monopolies immunize firms from competition, allowing them to charge very high prices."
"Elderly man kills wife because they couldn't afford her medicine
A good chunk of Greensboro's health care industry is comprised of thieves
supported and condoned by the 'government'
William J. Hager of Port St. Lucie, Florida is a 86 year old man who confessed to shooting his 76 year old wife, Carolyn Hager, in her sleep, because the couple could no longer afford her medications, leaving her in pain and wanting to die."